2013 Oregon Revised Statutes
Volume : 11 - Public Health, Housing, Environment
Chapter 433 - Disease and Condition Control; Mass Gatherings; Indoor Air
Section 433.992 - Penalties for violation of ORS 433.329.

Violation of ORS 433.329 is punishable, upon conviction, as provided in ORS 431.990. [Formerly 437.990]

Note: Sections 1 and 2, chapter 175, Oregon Laws 2013, provide:

Sec. 1. Lysosomal storage disorders. (1) As used in this section, "lysosomal storage disorder" means Krabbe disease, Pompe disease, Gaucher disease, Fabry disease, Niemann-Pick disease or any other inherited metabolic disorder resulting from a defect in lysosomal functionality.

(2) The Oregon Health Authority shall conduct a study related to infants who have a lysosomal storage disorder and assess the feasibility of requiring infants born in this state to be screened and treated for lysosomal storage disorders. The authority shall report the results of the study to the Legislative Assembly, in the manner provided for in ORS 192.245, on or before March 1, 2015. [2013 c.175 §1]

Sec. 2. Section 1 of this 2013 Act is repealed on March 2, 2015. [2013 c.175 §2]

Note: Sections 1 and 2, chapter 333, Oregon Laws 2013, provide:

Sec. 1. Diabetes. The Oregon Health Authority shall report in the manner described in ORS 192.245 to the regular session of the Legislative Assembly not later than February 1, 2015, the following:

(1) The burden of diabetes in this state as measured by:

(a) The estimated prevalence of diagnosed and undiagnosed adult diabetes and, for diagnosed diabetes, the estimated prevalence by age, race and sex;

(b) The estimated prevalence of prediabetes and of diagnosed Type I diabetes, Type II diabetes and gestational diabetes;

(c) The number of hospitalizations and the estimated cost of hospitalizations due to diabetes and due to heart disease in patients diagnosed with diabetes;

(d) The estimated costs of hospitalizations for diabetes compared to hospitalizations for other common chronic diseases;

(e) The National Quality Forum Measure 59, HbA1c Poor Control, publicly reported for coordinated care organizations, including the baseline measurements and all available quarterly data;

(f) The estimated prevalence of obesity and overweight in the most recent year for which data are readily available;

(g) The estimated direct and indirect costs of diabetes in the most recent year for which data are readily available;

(h) The estimated prevalence of diabetes among participants in Medicaid-funded state programs;

(i) The direct claims costs of diabetes to Medicaid-funded state programs;

(j) The estimated prevalence of diabetes among enrollees in health benefit plans offered by the Public Employees' Benefit Board;

(k) The direct claims costs to the Public Employees' Benefit Board for treating diabetes and diabetes-related complications;

(L) The estimated prevalence of diabetes among enrollees in health benefit plans offered by the Oregon Educators Benefit Board; and

(m) The direct claims costs to the Oregon Educators Benefit Board for treating diabetes and diabetes-related complications.

(2) The status of:

(a) The strategic plan to start to slow the rate of diabetes caused by obesity and other environmental factors by the year 2010 that was developed in accordance with section 2, chapter 460, Oregon Laws 2007, including the authority's current funding recommendations to complete the implementation of the plan; and

(b) Other strategies developed by the authority to reduce the impact of prediabetes, diabetes and diabetes-related complications including strategies to reduce hospitalizations and improve diabetes care for participants in state-funded health programs. [2013 c.333 §1]

Sec. 2. Section 1 of this 2013 Act is repealed on the date of the convening of the 2016 regular session of the Legislative Assembly [February 1, 2016]. [2013 c.333 §2]

Note: Sections 1 and 2, chapter 348, Oregon Laws 2013, provide:

Sec. 1. HPV. (1) In an effort to reduce the burden of the human papillomavirus and related cancers in this state, the Oregon Health Authority shall prepare a human papillomavirus and comprehensive related cancer control plan as an addendum to the Oregon Comprehensive Cancer Plan that assesses the following:

(a) Existing disease prevention or surveillance policies and programs;

(b) Existing disease prevention or surveillance measures;

(c) Public and health care provider awareness;

(d) Gaps in knowledge related to the human papillomavirus and related cancers; and

(e) Opportunities to improve disease prevention and surveillance policies, programs and measures.

(2) The plan must address, at a minimum, cervical cancer, anogenital cancer, oral cavity cancer and pharyngeal cancer.

(3) The authority shall submit the plan, along with recommendations for legislation, to the interim committees of the Legislative Assembly related to health on or before September 1, 2014. [2013 c.348 §1]

Sec. 2. Section 1 of this 2013 Act is repealed on January 2, 2015. [2013 c.348 §2]